Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide – CNBC By Weight Loss Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide CNBC Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug. Barron’s Amgen scraps experimental weight loss pill, moves forward with injection CNBC Brought to you by Google News. Read the rest of the article here. Facebook Twitter Pinterest